Elanco Animal Health (ELAN) has received a warning letter from the FDA related to promotional materials for its canine drug Zenrelia. Read more here.
Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.
FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. | The FDA ...
Outset Medical (OM) announced it has been notified by the FDA that all issues cited in a warning letter the company received in July of 2023 ...
Elanco Animal Health Incorporated issued the following statement regarding its commitment to clear veterinary and pet owner ...
The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...
Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...
Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S. Food and Drug Administration (FDA) dating ...
An Alabama senator has introduced a bill to ban intoxicating hemp products, such as delta-8 THC, making Alabama the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback